The 180 references in paper Editorial article , Редакционная статья (2015) “Международные клинические рекомендации для практических врачей по диагностике и лечению облитерирующего бронхиолита // International practical guidelines on diagnosis, prevention and treatment of bronchiolitis obliterans syndrome” / spz:neicon:pulmonology:y:2015:i:4:p:403-424

1
Burke C.M., Theodore J., Dawkins K.D. et al. Post\ntrans\n plant obliterative bronchiolitis and other late lung sequelae in human heart\nlung transplant recipients. Chest. 1984; 86: 824–829.
(check this in PDF content)
2
Christie J.D., Edwards L.B., Aurora P. et al. The registry of the International Society for Heart and Lung Transplantation: twenty\nsixth official adult lung and heart\n lung transplantation report\n2009. J. Heart Lung Transplant. 2009; 28: 1031–1049.
(check this in PDF content)
3
The International Society for Heart and Lung Trans\n plantation.www.ishlt.org
(check this in PDF content)
4
Cooper J.D., Billingham M., Egan T. et al. A working for\n mulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J. Heart Lung Transplant.1993; 12: 713–716.
(check this in PDF content)
5
Estenne M., Maurer J.R., Boehler A. et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic cri\n teria.J. Heart Lung Transplant.2002; 21: 297–310.
(check this in PDF content)
6
Bando K., Paradis I.L., Similo S. et al. Obliterative bron\n chiolitis after lung and heart\nlung transplantation. An analysis of risk factors and management. J. Thorac. Cardiovasc. Surg. 1995; 110: 4–13.
(check this in PDF content)
7
Reichenspurner H., Girgis R.E., Robbins R.C. et al. Stanford experience with obliterative bronchiolitis after lung and heart\nlung transplantation. Ann. Thorac. Surg. 1996; 62: 1467–1472.
(check this in PDF content)
8
Kramer M.R., Stoehr C., Whang J.L. et al. The diagnosis of obliterative bronchiolitis after heart\nlung and lung transplantation: low yield of transbronchial lung biopsy. J. Heart Lung Transplant.1993; 12: 675–681.
(check this in PDF content)
9
Pomerance A., Madden B., Burke M.M. et al. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J. Heart Lung Transplant. 1995; 14: 761–773.
(check this in PDF content)
10
Chamberlain D., Maurer J., Chaparro C. et al. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation.J. Heart Lung Transplant. 1994; 13: 963–971.
(check this in PDF content)
11
Burton C.M., Iversen M., Carlsen J. et al. Acute cellular rejection is a risk factor for bronchiolitis obliterans syn\n drome independent of post\ntransplant baseline FEV1. J. Heart Lung Transplant. 2009; 28: 888–893.
(check this in PDF content)
12
Schulman L.L., Weinberg A.D., McGregor C. et al. Mis\n matches at the HLA\nDR and HLA\nB loci are risk factors for acute rejection after lung transplantation. Am. J. Respir. Crit. Care Med. 1998; 157: 1833–1837.
(check this in PDF content)
13
Burlingham W.J., Love R.B., Jankowska\nGan E. et al. IL\n17\ndependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.J. Clin. Invest. 2007; 117: 3498–3506.
(check this in PDF content)
14
Belperio J.A., Weigt S., Fishbein M.C. et al. Chronic lung allograft rejection: mechanisms and therapy. Proc. Am. Thorac. Soc. 2009; 6: 108–121.
(check this in PDF content)
15
Weigt S.S., Wallace W.D., Derhovanessian A. et al. Chronic allograft rejection: epidemiology, diagnosis, pathogenesis, and treatment.Semin. Respir. Crit. Care Med. 2010; 31: 189–207.
(check this in PDF content)
16
Verleden G.M., Vos R., De Vleeschauwer S.I. et al. Obli\n terative bronchiolitis following lung transplantation: from old to new concepts?Transpl. Int.2009; 22: 771–779.
(check this in PDF content)
17
Schünemann H.J., Jaeschke R., Cook D.J. et al. An offi\n cial ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am. J. Respir. Crit. Care Med. 2006; 174: 605–614.
(check this in PDF content)
18
Sato M., Waddell T.K., Wagnetz U. et al. Restrictive allo\n graft syndrome (RAS): a novel form of chronic lung allo\n graft dysfunction. J. Heart Lung Transplant. 2011; 30: 735–742.
(check this in PDF content)
19
ama V.N., Murray S., Lonigro R.J. et al. Course of FEV1 after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am. J. Respir. Crit. Care Med.2007; 175: 1192–1198.
(check this in PDF content)
20
Woodrow J.P., Shlobin O.A., Barnett S.D. et al. Comparison of bronchiolitis obliterans syndrome to other forms of chronic lung allograft dysfunction after lung transplantation.J. Heart Lung Transplant.2010; 29: 1159–1164.
(check this in PDF content)
21
Jackson C.H., Sharples L.D., McNeil K. et al. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? J. Heart Lung Transplant.2002; 21: 658–666.
(check this in PDF content)
22
Brugière O., Pessione F., Thabut G. et al. Bronchiolitis obliterans syndrome after single\nlung transplantation: impact of time to onset on functional pattern and survival. Chest. 2002; 121: 1883–1889.
(check this in PDF content)
23
Burton C.M., Carlsen J., Mortensen J. et al. Long\nterm survival after lung transplantation depends on develop\n ment and severity of bronchiolitis obliterans syndrome. J. Heart Lung Transplant.2007; 26: 681–686.
(check this in PDF content)
24
Nathan S.D., Ross D.J., Belman M.J. et al. Bronchiolitis obliterans in single\nlung transplant recipients. Chest. 1995; 107: 967–972.
(check this in PDF content)
25
Vos R., Vanaudenaerde B.M., Ottevaere A. et al. Long\n term azithromycin therapy for bronchiolitis obliterans syn\n drome: divide and conquer?J. Heart Lung Transplant. 2010; 29: 1358–1368.
(check this in PDF content)
26
Gottlieb J., Szangolies J., Koehnlein T. et al. Long\nterm azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2008; 85: 36–41.
(check this in PDF content)
27
Vos R., Vanaudenaerde B.M., Verleden S.E. et al. A ran\n domised controlled trial of azithromycin to prevent bron\n chiolitis obliterans syndrome after lung transplantation. Eur. Respir. J. 2011; 37: 164–172.
(check this in PDF content)
28
Stewart S., Fishbein M.C., Snell G.I. et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J. Heart Lung Transplant. 2007; 26: 1229–1242.
(check this in PDF content)
29
Keller C.A., Cagle P.T., Brown R.W. et al. Bronchiolitis obliterans in recipients of single, double, and heart\nlung transplantation. Chest. 1995; 107: 973–980.
(check this in PDF content)
30
Girgis R.E., Tu I., Berry G.J. et al. Risk factors for the development of obliterative bronchiolitis after lung trans\n plantation. J. Heart Lung Transplant. 1996; 15: 1200–1208.
(check this in PDF content)
31
Kroshus T.J., Kshettry V.R., Savik K. et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.J. Thorac. Cardiovasc. Surg. 1997; 114: 195–202.
(check this in PDF content)
32
Heng D., Sharples L.D., McNeil K. et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J. Heart Lung Transplant. 1998; 17: 1255–1263.
(check this in PDF content)
33
Husain A.N., Siddiqui M.T., Holmes E.W. et al. Analysis of risk factors for the development of bronchiolitis obliter\n ans syndrome. Am. J. Respir. Crit. Care Med.1999; 159: 829–833.
(check this in PDF content)
34
El\nGamel A., Sim E., Hasleton P. et al. Transforming growth factor beta (TGF\nβ) and obliterative bronchilitis following pulmonary transplantation. J. Heart Lung Transplant.1999; 18: 828–837.
(check this in PDF content)
35
Sharples L.D., McNeil K., Stewart S. et al. Risk factors for bronchiolitis obliterans: a systematic review of recent pub\n lications.J. Heart Lung Transplant. 2002; 21: 271–281.
(check this in PDF content)
36
Burton C.M., Iversen M., Scheike T. et al. Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation. J. Heart Lung Transplant. 2008; 27: 1128–1134.
(check this in PDF content)
37
Glanville A.R., Aboyoun C.L., Havryk A. et al. Severity of lymphocytic bronchiolitis predicts long\nterm outcome after lung transplantation.Am. J. Respir. Crit. Care Med. 2008; 177: 1033–1040.
(check this in PDF content)
38
Ross D.J., Marchevsky A., Kramer M. et al. "Refractori\n ness" of airflow obstruction associated with isolated lym\n phocytic bronchiolitis / bronchitis in pulmonary allografts. J. Heart Lung Transplant.1997; 16: 832–838.
(check this in PDF content)
39
Guilinger R.A., Paradis I.L., Dauber J.H. et al. The importance of bronchoscopy with transbronchial biopsy and bronchoalveolar lavage in the management of lung transplant recipients. Am. J. Respir. Crit. Care Med.1995; 152: 2037–2043.
(check this in PDF content)
40
Levine S.M., Transplant / Immunology Network of the American College of Chest. Physicians. A survey of clini\n cal practice of lung transplantation in North America. Chest. 2004; 125: 1224–1238.
(check this in PDF content)
41
Hopkins P.M., Aboyoun C.L., Chhajed P.N. et al. Association of minimal rejection in lung transplant recipi\n ents with obliterative bronchiolitis.Am. J. Respir. Crit. Care Med.2004; 170: 1022–1026.
(check this in PDF content)
42
Hachem R.R., Khalifah A.P., Chakinala M.M. et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005; 80: 1406–1413.
(check this in PDF content)
43
Khalifah A.P., Hachem R.R., Chakinala M.M. et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am. J. Transplant. 2005; 5: 2022–2030.
(check this in PDF content)
44
Palmer S.M., Davis R.D., Hadjiliadis D. et al. Develop\n ment of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation. 2002; 74: 799–804.
(check this in PDF content)
45
Lau C.L., Palmer S.M., Posther K.E. et al. Influence of panel\nreactive antibodies on posttransplant outcomes in lung transplant recipients.Ann. Thorac. Surg. 2000; 69: 1520–1524.
(check this in PDF content)
46
Girnita A.L., Duquesnoy R., Yousem S.A. et al. HLA\nspe\n cific antibodies are risk factors for lymphocytic bronchioli\n tis and chronic lung allograft dysfunction. Am. J. Transplant.2005; 5: 131–138.
(check this in PDF content)
47
Sundaresan S., Mohanakumar T., Smith M.A. et al. HLA\n A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the develop\n ment of bronchiolitis obliterans syndrome. Transplantation. 1998; 65: 648–653.
(check this in PDF content)
48
Jaramillo A., Smith M.A., Phelan D. et al. Development of ELISA\ndetected anti\nHLA antibodies precedes the devel\n opment of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation. 1999; 67: 1155–1161.
(check this in PDF content)
49
Bharat A., Narayanan K., Street T. et al. Early posttrans\n plant inflammation promotes the development of alloim\n munity and chronic human lung allograft rejection. Transplantation. 2007; 83: 150–158.
(check this in PDF content)
50
Bharat A., Kuo E., Steward N. et al. Immunological link between primary graft dysfunction and chronic lung allo\n graft rejection. Ann. Thorac. Surg. 2008; 86: 189–195.
(check this in PDF content)
51
Daud S.A., Yusen R.D., Meyers B.F. et al. Impact of immediate primary lung allograft dysfunction on bronchi\n olitis obliterans syndrome. Am. J. Respir. Crit. Care Med. 2007; 175: 507–513.
(check this in PDF content)
52
Huang H.J., Yusen R.D., Meyers B.F. et al. Late primary graft dysfunction after lung transplantation and bronchi\n olitis obliterans syndrome. Am. J. Transplant.2008; 8: 2454–2462.
(check this in PDF content)
53
Botha P., Archer L., Anderson R.L. et al. Pseudomonas aeruginosa colonization of the allograft after lung trans\n plantation and the risk of bronchiolitis obliterans syn\n drome. Transplantation. 2008; 85: 771–774.
(check this in PDF content)
54
Vos R., Vanaudernaerde B.M., De Vleeschauwer S.I. et al. De novo or persistent pseudomonal airway colonization after lung transplantation: importance for bronchiolitis obliterans syndrome? Transplantation. 2008; 86: 624–625.
(check this in PDF content)
55
Gottlieb J., Mattner F., Weissbrodt H. et al. Impact of graft colonization with Gram\nnegative bacteria after lung trans\n plantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis. Respir. Med. 2009; 103: 743–749.
(check this in PDF content)
56
Keenan R.J., Lega M.E., Dummer J.S. et al. Cytomega\n lovirus serologic status and postoperative infection correlat\n ed with risk of developing chronic rejection after pulmonary transplantation. Transplantation. 1991; 51: 433–438.
(check this in PDF content)
57
Smith M.A., Sundaresan S., Mohanakumar T. et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and develop\n ment of bronchiolitis syndrome.J. Thorac. Cardiovasc. Surg. 1998; 116; 812–820.
(check this in PDF content)
58
Engelmann I., Welte T., Fühner T. et al. Detection of Epstein\nBarr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J. Clin. Virol.2009; 45: 47–53.
(check this in PDF content)
59
Kumar D., Erdman D., Keshavjee S. et al. Clinical impact of community\nacquired respiratory viruses on bronchioli\n tis obliterans after lung transplant.Am. J. Transplant.2005; 5: 2031–2036.
(check this in PDF content)
60
Bridges N.D., Spray T.L., Collins M.H. et al. Adenovirus infection in the lung results in graft failure after lung trans\n plantation.J. Thorac. Cardiovasc. Surg. 1998; 116: 617–623.
(check this in PDF content)
61
Khalifah A.P., Hachem R.R., Chakinala M.M. et al. Respiratory viral infections are a distinct risk for bronchi\n olitis obliterans syndrome and death.Am. J. Respir. Crit. Care Med.2004; 170: 181–187.
(check this in PDF content)
62
Billings J.L., Hertz M.I., Savik K. et al. Respiratory virus\n es and chronic rejection in lung transplant recipients. J. Heart Lung Transplant. 2002; 21: 559–566.
(check this in PDF content)
63
Vilchez R.A., Dauber J., McCurry K. et al. Parainfluenza virus infection in adult lung transplant recipients: an emer\n gent clinical syndrome with implications on allograft func\n tion.Am. J. Transplant.2003; 3: 116–120.
(check this in PDF content)
64
Palmer S.M. Jr, Henshaw N.G., Howell D.N. et al. Community respiratory viral infection in adult lung trans\n plant recipients. Chest. 1998; 113: 944–950.
(check this in PDF content)
65
D , Ovidio F., Singer L.G., Hadjiliadis D. et al. Prevalence of gastroesophageal reflux in end\nstage lung disease candi\n dates for lung transplant. Ann. Thorac. Surg.2005; 80: 1254–1260.
(check this in PDF content)
66
Blondeau K., Mertens V., Vanaudenaerde B.A. et al. Gastro\noesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur. Respir. J.2008; 31: 707–713.
(check this in PDF content)
67
King B.J., Iyer H., Leidi A.A. et al. Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspec\n tive.J. Heart Lung Transplant.2009; 28: 870–875.
(check this in PDF content)
68
Hadjiliadis D., Duane Davis R., Steele M.P. et al. Gastro\n esophageal reflux disease in lung transplant recipients. Clin. Transplant. 2003; 17: 363–368.
(check this in PDF content)
69
Valentine V.G., Gupta M.R., Walker J.E. Jr et al. Effect of etiology and timing of respiratory tract infections on devel\n opment of bronchiolitis obliterans syndrome. J. Heart Lung Transplant.2009; 28: 163–169.
(check this in PDF content)
70
Weigt S.S., Elashoff R.M., Huang C. et al. Aspergillus colonization of the lung allograft is a risk factor for bron\n chiolitis obliterans syndrome. Am. J. Transplant. 2009; 9: 1903–1911.
(check this in PDF content)
71
Weigt S.S., Copeland C.A., Derhovanessian A. et al. Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two\n center validation study. Am. J. Transplant.2013; 13: 919–927.
(check this in PDF content)
72
Gandhi M.K., Khanna R. Human cytomegalovirus: clini\n cal aspects, immune regulation, and emerging treatments. Lancet Infect. Dis. 2004; 4: 725–738.
(check this in PDF content)
73
Ibrahim L., Dominguez M., Yacoub M. Primary human adult lung epithelial cells in vitro: response to interferon\nγ and cytomegalovirus. Immunology. 1993; 79: 119–124.
(check this in PDF content)
74
Geist L.J., Dai L.Y. Cytomegalovirus modulates inter\n leukin\n6 gene expression. Transplantation. 1996; 62: 653–658.
(check this in PDF content)
75
Vos R., Vanaudenaerde B.M., Dupont L.J. et al. Transient airway colonization is associated with airway inflammation after lung transplantation. Am. J. Transplant.2007; 7: 1278–1287.
(check this in PDF content)
76
Bobadilla J.L., Jankowska\nGan E., Xu Q. et al. Reflux\n induced collagen type V sensitization: potential mediator of bronchiolitis obliterans syndrome. Chest. 2010; 138: 363–370.
(check this in PDF content)
77
Saini D., Weber J., Ramachandran S. et al. Alloimmunity\n induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J. Heart Lung Transplant.2011; 30: 624–631.
(check this in PDF content)
78
Henke J.A., Golden J.A., Yelin E.H. et al. Persistent increase of BAL neutrophils as a predictor of mortality fol\n lowing lung transplant. Chest. 1999; 115: 403–409.
(check this in PDF content)
79
Meyer K.C., Nunley D.R., Dauber J.H. et al. Neutrophils, unopposed neutrophil elastase, and a1\nantiprotease defenses following human lung transplantation. Am. J. Respir. Crit. Care Med. 2001; 164: 97–102.
(check this in PDF content)
80
Reynaud\nGaubert M., Marin V., Thirion X. et al. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post\ntransplant airway oblit\n eration.J. Heart Lung Transplant.2002; 21: 721–730.
(check this in PDF content)
81
DiGiovine B., Lynch J.P. 3rd, Martinez F.J. et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL\n8.J. Immunol.1996; 157: 4194–4202.
(check this in PDF content)
82
Neurohr C., Huppmann P., Leuchte H. et al. Human her\n pesvirus 6 in bronchoalveolar lavage fluid after lung trans\n plantation: a risk factor for bronchiolitis obliterans syn\n drome? Am. J. Transplant.2005; 5: 2982–2991.
(check this in PDF content)
83
Schloma J., Slebos D.J., Boezen H.M. et al. Eosinophilic granulocytes and interleukin\n6 level in bronchoalveolar lavage fluid are associated with the development of obliter\n ative bronchiolitis after lung transplantation. Am. J. Respir. Crit. Care Med.2000; 162: 2221–2225.
(check this in PDF content)
84
Lama V.N., Murray S., Mumford J.A. et al. Prognostic value of bronchiolitis obliterans syndrome stage 0\np in sin\n glelung transplant recipients. Am. J. Respir. Crit. Care Med. 2005; 172: 379–383.
(check this in PDF content)
85
Hachem R.R., Chakinala M.M., Yusen R.D. et al. The predictive value of bronchiolitis obliterans syndrome stage 0\np. Am. J. Respir. Crit. Care Med. 2004; 169: 468–472.
(check this in PDF content)
86
Nathan S.D., Barnett S.D., Wohlrab J. et al. Bronchiolitis obliterans syndrome: utility of the new guidelines in single lung transplant recipients. J. Heart Lung Transplant. 2003; 22: 427–432.
(check this in PDF content)
87
Morrish W.F., Herman S.J., Weisbrod G.L. et al. Bronchiolitis obliterans after lung transplantation: findings at chest radiography and high resolution CT. The Toronto Lung Transplant Group. Radiology. 1991; 179: 487–490.
(check this in PDF content)
88
Kundu S., Herman S.J., Larhs A. et al. Correlation of chest radiographic findings with biopsy\nproven acute lung rejection. J. Thorac. Imaging. 1999; 14: 178–184.
(check this in PDF content)
89
Collins J. Imaging of the Chest. after lung transplantation. J. Thorac. Imaging.2002; 17: 102–112.
(check this in PDF content)
90
Leung A.N., Fisher K., Valentine V. et al. Bronchiolitis obliterans after lung transplantation: detection using expi\n ratory HRCT. Chest. 1998; 113: 365–370.
(check this in PDF content)
91
Bankier A.A., Van Muylem A., Knoop C. et al. Bronchiolitis obliterans syndrome in heart\nlung transplant recipients: diagnosis with expiratory CT. Radiology. 2001; 218: 533–539.
(check this in PDF content)
92
Lee E.S., Gotway M.B., Reddy G.P. et al. Early bronchi\n olitis obliterans following lung transplantation: accuracy of expiratory thin\nsection CT for diagnosis. Radiology. 2000; 216: 472–477.
(check this in PDF content)
93
Berstad A.E., Aaløkken T.M., Kolbenstvedt A. et al. Performance of long\nterm CT monitoring in diagnosing bronchiolitis obliterans after lung transplantation. Eur. J. Radiol.2006; 58: 124–131.
(check this in PDF content)
94
Konen E., Gutierrez C., Chaparro C. et al. Bronchiolitis obliterans syndrome in lung transplant recipients: can thinsection CT findings predict disease before its clinical appearance? Radiology. 2004; 231: 467–473.
(check this in PDF content)
95
Tepper R.S., Reister T. Forced expiratory flows and lung volumes in normal infants. Pediatr. Pulmonol. 1993; 15: 357–361.
(check this in PDF content)
96
Castile R., Filbrun D., Flucke R. et al. Adult\ntype pul\n monary function tests in infants without respiratory dis\n ease. Pediatr. Pulmonol. 2000; 30: 215–227.
(check this in PDF content)
97
Siegel M.J., Bhalla S., Gutierrez F.R. et al. Post\nlung transplantation bronchiolitis obliterans syndrome: useful\n ness of expiratory thin\nsection CT for diagnosis. Radiology. 2001; 220: 455–462.
(check this in PDF content)
98
Buttgereit F., da Silva J.A., Boers M. et al. Standardised nomenclature for glucocorticoid dosages and glucocorti\n coid treatment regimens: current questions and tentative answers in rheumatology. Ann. Rheum. Dis. 2002; 61: 718–722.
(check this in PDF content)
99
Ross D.J., Lewis M.I., Kramer M. et al. FK 506 "rescue" immunosuppression for obliterative bronchiolitis after lung transplantation. Chest. 1997; 112: 1175–1179.
(check this in PDF content)
100
Borro J.M., Bravo C., Solè A. et al. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome. Transplant. Proc.2007; 39: 2416–2419.
(check this in PDF content)
101
Knoop C., Antoine M., Vachièry J.L. et al. FK 506 rescue therapy for irreversible airway rejection in heart\nlung transplant recipients: report on five cases. Transplant. Proc. 1994; 26: 3240–3241.
(check this in PDF content)
102
Reichenspurner H., Meiser B.M., Kur F. et al. First expe\n rience with FK 506 for treatment of chronic pulmonary rejection. Transplant. Proc.1995; 27: 2009.
(check this in PDF content)
103
Kesten S., Chaparro C., Scavuzzo M. et al. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 1997; 16: 905–912.
(check this in PDF content)
104
Mentzer R.M. Jr, Jahania M.S., Lasley R.D. Tacrolimus as a rescue immunosuppressant after heart and lung trans\n plantation. The U.S. Multicenter FK506 Study Group. Transplantation. 1998; 65: 109–113.
(check this in PDF content)
105
Revell M.P., Lewis M.E., Llewellyn\nJones C.G. et al. Conservation of small\nairway function by tacrolimus / cyclosporine conversion in the management of bronchioli\n tis obliterans following lung transplantation. J. Heart Lung Transplant.2000; 19: 1219–1223.
(check this in PDF content)
106
Fieguth H.G., Krueger S., Wiedenmann D.E. et al. Tacro\n limus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation. Transplant. Proc. 2002; 34: 1884.
(check this in PDF content)
107
Cairn J., Yek T., Banner N.R. et al. Time\nrelated changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 2003; 22: 50–57.
(check this in PDF content)
108
Sarahrudi K., Estenne M., Corris P. et al. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. J. Thorac. Cardiovasc. Surg.2004; 127: 1126–1132.
(check this in PDF content)
109
Webster A., Woodroffe R.C., Taylor R.S. et al. Tacrolimus versus cyclosporin as primary immunosuppression for kid\n ney transplant recipients. Cochrane Database Syst. Rev. 2005; 4: CD003961.
(check this in PDF content)
110
Gerhardt S.G., McDyer J.F., Girgis R.E. et al. Mainte\n nance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.Am. J. Respir. Crit. Care Med. 2003; 168: 121–125.
(check this in PDF content)
111
Verleden G.M., Dupont L.J. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2004; 77: 1465–1467.
(check this in PDF content)
112
Yates B., Murphy D.M., Forrest I.A. et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.Am. J. Respir. Crit. Care Med. 2005; 172: 772–775.
(check this in PDF content)
113
Shitrit D., Bendayan D., Gidon S. et al. Long\nterm azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.J. Heart Lung Transplant.2005; 24: 1440–1443.
(check this in PDF content)
114
Verleden G.M., Vanaudenaerde B.M., Dupont L.J. et al. Azithromycin reduces airway neutrophilia and interleukin\n 8 in patients with bronchiolitis obliterans syndrome. Am. J. Respir. Crit. Care Med.2006; 174: 566–570.
(check this in PDF content)
115
Porhownik N.R., Batobara W., Kepron W. et al. Effect of maintenance azithromycin on established bronchiolitis obliterans syndrome in lung transplant patients. Can. Respir. J.2008; 15: 199–202.
(check this in PDF content)
116
Jain R., Hachem R.R., Morrell M.R. et al. Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome.J. Heart Lung Transplant.2010; 29: 531–537.
(check this in PDF content)
117
Panpanich R., Lerttrakarnnon P., Laopaiboon M. Azi\n thromycin for acute lower respiratory tract infections. Cochrane Database Syst. Rev.2008; 1: CD001954.
(check this in PDF content)
118
Svanström H., Pasternak B., Hviid A. Use of azithromycin and death from cardiovascular causes. N. Engl. J. Med. 2013; 368: 1704–1712.
(check this in PDF content)
119
US Food and Drug Administration. FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. www.fda.gov/ drugs/drugsafety/ucm341822.htmDate last accessed: September 11, 2013. Date last updated: March 18, 2013.
(check this in PDF content)
120
Albert R.K., Connett J., Bailey W.C. et al. Azithromycin for prevention of exacerbations of COPD. N. Engl. J. Med. 2011; 365: 689–698.
(check this in PDF content)
121
Young L.R., Hadjiliadis D., Davis R.D. et al. Lung trans\n plantation exacerbates gastroesophageal reflux disease. Chest. 2003; 124: 1689–1693.
(check this in PDF content)
122
Sweet M.P., Patti M.G., Leard L.E. et al. Gastro\n esophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J. Thorac. Cardiovasc. Surg.2007; 133: 1078–1084.
(check this in PDF content)
123
Linden P.A., Gilbert R.J., Yeap B.Y. et al. Laparoscopic fundoplication in patients with end\nstage lung disease awaiting transplantation. J. Thorac. Cardiovasc. Surg. 2006; 131: 438–446.
(check this in PDF content)
124
Gasper W.J., Sweet M.P., Hoopes C. et al. Antireflux sur\n gery for patients with end\nstage lung disease before and after lung transplantation. Surg. Endosc. 2008; 22: 495–500.
(check this in PDF content)
125
Benden C., Aurora P., Curry J. et al. High prevalence of gastroesophageal reflux disease in lung transplant recipi\n ents. Pediatr. Pulmonol.2005; 40: 68–71.
(check this in PDF content)
126
O'Halloran E.K., Reynolds J.D., Lau C.L. et al. Lapa\n roscopic Nissen fundoplication for treating reflux in lung transplant recipients.J. Gastrointest. Surg. 2004; 8: 132–137.
(check this in PDF content)
127
Davis R.D. Jr, Lau C.L., Eubanks S. et al. Improved lung allograft function after fundoplication in patients with gas\n troesophageal reflux disease undergoing lung transplanta\n tion.J. Thorac. Cardiovasc. Surg. 2003; 125: 533–542.
(check this in PDF content)
128
Cantu E. 3rd, Appel J.Z. 3rd, Hartwig M.G. et al. J. Max\n well Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gas\n troesophageal reflux disease.Ann. Thorac. Surg. 2004; 78: 1142–1151.
(check this in PDF content)
129
Davis C.S., Gagermeier J., Dilling D. et al. A review of the potential applications and controversies of non\ninvasive testing for biomarkers of aspiration in the lung transplant population.Clin. Transplant.2010; 24: E54–E61.
(check this in PDF content)
130
D , Ovidio F., Mura M., Tsang M. et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation.J. Thorac. Cardiovasc. Surg. 2005; 129: 1144–1152.
(check this in PDF content)
131
Hopkins P.M., Kermeen F., Duhig E. et al. Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipi\n ents.J. Heart Lung Transplant. 2010; 29: 859–864.
(check this in PDF content)
132
Lau C.L., Palmer S.M., Howell D.N. et al. Laparoscopic antireflux surgery in the lung transplant population. Surg. Endosc.2002; 16: 1674–1678.
(check this in PDF content)
133
Zheng C., Kane T.D., Kurland G. et al. Feasibility of laparoscopic Nissen fundoplication after pediatric lung or heartlung transplantation: should this be the standard? Surg. Endosc.2011; 25: 249–254.
(check this in PDF content)
134
Burton P.R., Button B., Brown W. et al. Medium\nterm outcome of fundoplication after lung transplantation.Dis. Esophagus. 2009; 22: 642–648.
(check this in PDF content)
135
Fisichella P.M., Davis C.S., Gagermeier J. et al. Laparo\n scopic antireflux surgery for gastroesophageal reflux dis\n ease after lung transplantation.J. Surg. Res. 2011; 170: e279–e286.
(check this in PDF content)
136
Hartwig M.G., Anderson D.J., Onaitis M.W. et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann. Thorac. Surg. 2011; 92: 462–468.
(check this in PDF content)
137
Hoppo T., Jarido V., Pennathur A. et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end\nstage lung disease before and after lung transplantation. Arch. Surg. 2011; 146: 1041–1047.
(check this in PDF content)
138
Fisichella P.M., Davis C.S., Lundberg P.W. et al. The pro\n tective role of laparoscopic antireflux surgery against aspi\n ration of pepsin after lung transplantation. Surgery. 2011; 150: 598–606.
(check this in PDF content)
139
Wang Z., Zheng Q., Jin Z. Meta\nanalysis of robot\nassisted versus conventional laparoscopic Nissen fundoplication for gastro\noesophageal reflux disease.ANZ J. Surg.2012; 82: 112–117.
(check this in PDF content)
140
Khatri K., Sajid M.S., Brodrick R. et al. Laparoscopic Nissen fundoplication with or without short gastric vessel division: a meta\nanalysis. Surg. Endosc.2012; 26: 970–978.
(check this in PDF content)
141
Brugière O., Thabut G., Castier Y. et al. Lung retransplan\n tation for bronchiolitis obliterans syndrome: long\nterm follow\nup in a series of 15 recipients. Chest. 2003; 123: 1832–1837.
(check this in PDF content)
142
Strueber M., Fischer S., Gottlieb J. et al. Long\nterm out\n come after pulmonary retransplantation. J. Thorac. Cardiovasc. Surg. 2006; 132: 407–412.
(check this in PDF content)
143
Aigner C., Jaksch P., Taghavi S. et al. Pulmonary retrans\n plantation: is it worth the effort? A long\nterm analysis of 46 cases. J. Heart Lung Transplant. 2008; 27: 60–65.
(check this in PDF content)
144
Osaki S., Maloney J.D., Meyer K.C. et al. Redo lung transplantation for acute and chronic lung allograft failure: longterm follow\nup in a single center. Eur. J. Cardiothorac. Surg. 2008; 34: 1191–1197.
(check this in PDF content)
145
Novick R.J., Stitt L., Schäfers H.J. et al. Pulmonary retransplantation: does the indication for operation influ\n ence postoperative lung function? J. Thorac. Cardiovasc. Surg. 1996; 112: 1504–1513.
(check this in PDF content)
146
Novick R.J., Stitt L.W., Al\nKattan K. et al. Pulmonary retransplantation: predictors of graft function and survival in 230 patients.Pulmonary Retransplant Registry. Ann. Thorac. Surg. 1998; 65: 227–234.
(check this in PDF content)
147
Kawut S.M., Lederer D.J., Keshavjee S. et al. Outcomes after lung retransplantation in the modern era. Am. J. Respir. Crit. Care Med. 2008; 177: 114–120.
(check this in PDF content)
148
Keshavjee S. Retransplantation of the lung comes of age. J. Thorac. Cardiovasc. Surg. 2006; 132: 226–228.
(check this in PDF content)
149
Sato M., Ohmori\nMatsuda K., Saito T. et al. Time\n dependent changes in the risk of death in pure bronchioli\n tis obliterans syndrome (BOS).J. Heart Lung Transplant. 2013; 32: 484–491.
(check this in PDF content)
150
Vanaudenaerde B.M., De Vleeschauwer S.I., Vos R. et al. The role of the IL23 / IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am. J. Transplant. 2008; 8: 1911–1920.
(check this in PDF content)
151
Serody J.S., Hill G.R. The IL\n17 differentiation pathway and its role in transplant outcome. Biol. Blood. Marrow. Transplant.2012; 18: S56–S61.
(check this in PDF content)
152
Shilling R.A., Wilkes D.S. Role of Th17 cells and IL\n17 in lung transplant rejection. Semin. Immunopathol.2011; 33: 129–134.
(check this in PDF content)
153
Vanaudenaerde B.M., Verleden S.E., Vos R. et al. Innate and adaptive interleukin\n17\nproducing lymphocytes in chronic inflammatory lung disorders. Am. J. Respir. Crit. Care Med.2011; 183: 977–986.
(check this in PDF content)
154
Afzali B., Lombardi G., Lechler R.I. et al. The role of T helper 17 (Th17) and regulatory T\ncells (Treg) in human organ transplantation and autoimmune disease. Clin. Exp. Immunol. 2007; 148: 32–46.
(check this in PDF content)
155
Fan L., Benson H.L., Vittal R. et al. Neutralizing IL\n17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am. J. Transplant.2011; 11: 911–922.
(check this in PDF content)
156
Vittal R., Fan L., Greenspan D.S. et al. IL\n17 induces type V collagen overexpression and EMT via TGF\nb dependent pathways in obliterative bronchiolitis. Am. J. Physiol. Lung Cell. Mol. Physiol.2013; 304: L401–L414.
(check this in PDF content)
157
Bettelli E., Carrier Y., Gao W. et al. Reciprocal develop\n mental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006; 441: 235–238.
(check this in PDF content)
158
Neujahr D.C., Larsen C.P. Regulatory T cells in lung transplantation – an emerging concept. Semin. Immunopathol.2011; 33: 117–127.
(check this in PDF content)
159
Tiriveedhi V., Takenaka M., Ramachandran S. et al. T reg\n ulatory cells play a significant role in modulating MHC class I antibody\ninduced obliterative airway disease. Am. J. Transplant.2012; 12: 2663–2674.
(check this in PDF content)
160
Shi Q., Cao H., Liu J. et al. CD4+Foxp3+regulatory T\ncells induced by TGF\nb, IL\n2 and all\ntrans retinoic acid attenuate obliterative bronchiolitis in rat trachea trans\n plantation. Int. Immunopharmacol.2011; 11: 1887–1894.
(check this in PDF content)
161
Braun R.K., Molitor\nDart M., Wigfield C. et al. Transfer of tolerance to collagen type V suppresses T\nhelper\ncell\n 17 lymphocyte\nmediated acute lung transplant rejection. Transplantation. 2009; 88: 1341–1348.
(check this in PDF content)
162
Griffin D.O., Rothstein T.L. Human "orChest.rator" CD11b+B1\ncells spontaneously secrete interleukin\n10 and regulate T\ncell activity. Mol. Med. 2012; 18: 1003–1008.
(check this in PDF content)
163
Li W., Bribriesco A.C., Nava R.G. et al. Lung transplant acceptance is facilitated by early events in the graft and is associated with lymphoid neogenesis. Mucosal. Immunol. 2012; 5: 544–554.
(check this in PDF content)
164
Ward C., Forrest I.A., Murphy D.M. et al. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipi\n ents. Thorax. 2005; 60: 865–871.
(check this in PDF content)
165
Hodge S., Holmes M., Banerjee B. et al. Posttransplant bronchiolitis obliterans syndrome is associated with bronchial epithelial to mesenchymal transition. Am. J. Transplant. 2009; 9: 727–733.
(check this in PDF content)
166
Borthwick L.A., Parker S.M., Brougham K.A. et al. Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. Thorax. 2009; 64: 770–777.
(check this in PDF content)
167
Gardner A., Fisher A.J., Richter C. et al. The critical role of TAK1 in accentuated epithelial to mesenchymal transi\n tion in obliterative bronchiolitis after lung transplantation. Am. J. Pathol. 2012; 180: 2293–2308.
(check this in PDF content)
168
Cypel M., Yeung J.C., Hirayama S. et al. Technique for prolonged normothermic ex vivo lung perfusion. J. Heart Lung Transplant. 2008; 27: 1319–1325.
(check this in PDF content)
169
Cypel M., Rubacha M., Yeung J. et al. Normothermic ex vivo perfusion prevents lung injury compared to extended cold preservation for transplantation. Am. J. Transplant. 2009; 9: 2262–2269.
(check this in PDF content)
170
Ingemansson R., Eyjolfsson A., Mared L. et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo.Ann. Thorac. Surg. 2009; 87: 255–260.
(check this in PDF content)
171
Aigner C., Slama A., Hötzenecker K. et al. Clinical ex vivo lung perfusion – pushing the limits. Am. J. Transplant. 2012; 12: 1839–1847.
(check this in PDF content)
172
Zych B., Popov A.F., Stavri G. et al. Early outcomes of bilateral sequential single lung transplantation after ex\n vivo lung evaluation and reconditioning. J. Heart Lung Transplant. 2012; 31: 274–281.
(check this in PDF content)
173
Fisher A.J., Rutherford R.M., Bozzino J. et al. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplanta\n tion.Am. J. Transplant.2005; 5: 537–543.
(check this in PDF content)
174
Diamond D.A., Michalski J.M., Lynch J.P. et al. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. Int. J. Radiat. Oncol. Biol. Phys. 1998; 41: 795–800.
(check this in PDF content)
175
Benden C., Speich R., Hofbauer G.F. et al. Extracorporeal photopheresis after lung transplantation: a 10\nyear single\n center experience. Transplantation. 2008; 86: 1625–1627.
(check this in PDF content)
176
Morrell M.R., Despotis G.J., Lublin D.M. et al. The effi\n cacy of photopheresis for bronchiolitis obliterans syn\n drome after lung transplantation. J. Heart Lung Transplant.2010; 29: 424–431.
(check this in PDF content)
177
Cahill B.C., Somerville K.T., Crompton J.A. et al. Early experience with sirolimus in lung transplant recipients with chronic allograft rejection. J. Heart Lung Transplant. 2003; 22: 169–176.
(check this in PDF content)
178
Reams B.D., Musselwhite L.W., Zaas D.W. et al. Alemtuzumab in the treatment of refractory acute rejec\n tion and bronchiolitis obliterans syndrome after human lung transplantation. Am. J. Transplant.2007; 7: 2802–2808.
(check this in PDF content)
179
Shyu S., Dew M.A., Pilewski J.M. et al. Five\nyear out\n comes with alemtuzumab induction after lung transplanta\n tion.J. Heart Lung Transplant. 2011; 30: 743–754.
(check this in PDF content)
180
Cai J., Terasaki P.I. Induction immunosuppression improves long\nterm graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data. Transplantation. 2010; 90: 1511–1515.
(check this in PDF content)